Camp RL - Search Results

1

Automated quantitative analysis of tissue microarrays reveals an association between high Bcl-2 expression and improved outcome in melanoma.

Divito KA, Berger AJ, Camp RL, Dolled-Filhart M, Rimm DL, Kluger HM. Divito KA, et al. Among authors: camp rl. Cancer Res. 2004 Dec 1;64(23):8773-7. doi: 10.1158/0008-5472.CAN-04-1387. Cancer Res. 2004. PMID: 15574790

2

Quantitative determination of nuclear and cytoplasmic epidermal growth factor receptor expression in oropharyngeal squamous cell cancer by using automated quantitative analysis.

Psyrri A, Yu Z, Weinberger PM, Sasaki C, Haffty B, Camp R, Rimm D, Burtness BA. Psyrri A, et al. Clin Cancer Res. 2005 Aug 15;11(16):5856-62. doi: 10.1158/1078-0432.CCR-05-0420. Clin Cancer Res. 2005. PMID: 16115926

3

Vascular endothelial growth factor, FLT-1, and FLK-1 analysis in a pancreatic cancer tissue microarray.

Chung GG, Yoon HH, Zerkowski MP, Ghosh S, Thomas L, Harigopal M, Charette LA, Salem RR, Camp RL, Rimm DL, Burtness BA. Chung GG, et al. Among authors: camp rl. Cancer. 2006 Apr 15;106(8):1677-84. doi: 10.1002/cncr.21783. Cancer. 2006. PMID: 16532435 Free article.

4

Quantitative in situ analysis of beta-catenin expression in breast cancer shows decreased expression is associated with poor outcome.

Dolled-Filhart M, McCabe A, Giltnane J, Cregger M, Camp RL, Rimm DL. Dolled-Filhart M, et al. Among authors: camp rl. Cancer Res. 2006 May 15;66(10):5487-94. doi: 10.1158/0008-5472.CAN-06-0100. Cancer Res. 2006. PMID: 16707478

5

Evaluation of the prognostic value of cellular inhibitor of apoptosis protein in epithelial ovarian cancer using automated quantitative protein analysis.

Psyrri A, Yu Z, Bamias A, Weinberger PM, Markakis S, Kowalski D, Camp RL, Rimm DL, Dimopoulos MA. Psyrri A, et al. Among authors: camp rl. Cancer Epidemiol Biomarkers Prev. 2006 Jun;15(6):1179-83. doi: 10.1158/1055-9965.EPI-06-0120. Cancer Epidemiol Biomarkers Prev. 2006. PMID: 16775178

6

Expression of tumor necrosis factor--related apoptosis-inducing ligand receptors 1 and 2 in melanoma.

McCarthy MM, DiVito KA, Sznol M, Kovacs D, Halaban R, Berger AJ, Flaherty KT, Camp RL, Lazova R, Rimm DL, Kluger HM. McCarthy MM, et al. Among authors: camp rl. Clin Cancer Res. 2006 Jun 15;12(12):3856-63. doi: 10.1158/1078-0432.CCR-06-0190. Clin Cancer Res. 2006. PMID: 16778114 Free PMC article.

7

Classification of breast cancer using genetic algorithms and tissue microarrays.

Dolled-Filhart M, Rydén L, Cregger M, Jirström K, Harigopal M, Camp RL, Rimm DL. Dolled-Filhart M, et al. Among authors: camp rl. Clin Cancer Res. 2006 Nov 1;12(21):6459-68. doi: 10.1158/1078-0432.CCR-06-1383. Clin Cancer Res. 2006. PMID: 17085660

8

Antibody validation by quantitative analysis of protein expression using expression of Met in breast cancer as a model.

Pozner-Moulis S, Cregger M, Camp RL, Rimm DL. Pozner-Moulis S, et al. Among authors: camp rl. Lab Invest. 2007 Mar;87(3):251-60. doi: 10.1038/labinvest.3700515. Epub 2007 Jan 29. Lab Invest. 2007. PMID: 17260003 Free article.

9

Quantitative analysis of breast cancer tissue microarrays shows high cox-2 expression is associated with poor outcome.

Zerkowski MP, Camp RL, Burtness BA, Rimm DL, Chung GG. Zerkowski MP, et al. Among authors: camp rl. Cancer Invest. 2007 Feb;25(1):19-26. doi: 10.1080/07357900601128825. Cancer Invest. 2007. PMID: 17364553

10

High HSP90 expression is associated with decreased survival in breast cancer.

Pick E, Kluger Y, Giltnane JM, Moeder C, Camp RL, Rimm DL, Kluger HM. Pick E, et al. Among authors: camp rl. Cancer Res. 2007 Apr 1;67(7):2932-7. doi: 10.1158/0008-5472.CAN-06-4511. Cancer Res. 2007. PMID: 17409397

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

124 results

Search Page

Filters